• CCK-8 in BMSC Osteoporosis Research

  2026-09-10

  Discover how cck8 can support quantitative cell-state analysis in BMSC osteoporosis experiments, from treatment-window optimization to orthogonal validation. This guide connects WST-8 assay chemistry with the taraxasterol–PI3K/AKT/PPARγ findings reported in a recent mechanistic study.

• How HBsAg Rewires TBK1, Interferon, and Autophagy

  2026-09-10

  The reference study identifies a mechanism by which hepatitis B surface antigen (HBsAg) redirects TANK-binding kinase 1 (TBK1) away from effective IRF3 activation while promoting early, incomplete autophagy. By combining molecular interaction studies, pharmacological perturbation, animal models, and human liver samples, the work links TBK1 dimerization, p62 phosphorylation, impaired SNAP29 transcription, and HBV persistence.

• YAP–TEAD Links PPARα to Liver Growth and Regeneration

  2026-09-09

  The reference study identifies YAP–TEAD signaling as a functional mediator of PPARα-driven hepatomegaly and liver regeneration in mice. By combining conditional knockout models, pharmacological inhibition, gene silencing, partial hepatectomy, and tissue readouts, it connects a metabolic nuclear receptor to a growth-control pathway with implications for metabolic disorder research and liver repair biology.

• Mavorixafor Hydrochloride: CXCR4 Antagonist Guide

  2026-09-09

  AMD-070 hydrochloride is the hydrochloride salt of mavorixafor, an oral CXCR4 antagonist that blocks CXCR4/CXCL12 signaling. Its strongest translational rationale is in WHIM syndrome and CXCR4-mutated Waldenström macroglobulinemia, while anti-HIV research remains a mechanistic and assay-focused application.

• n-Dodecyl-β-D-maltoside for WecA Assays

  2026-09-08

  Use DDM to build a controlled solubilization-to-kinetics workflow for difficult 11-pass membrane enzymes such as Mycobacterium tuberculosis WecA. This guide connects detergent screening, affinity purification, UMP-based activity measurements, and troubleshooting without treating one concentration as universally optimal.

• Bestatin Reveals Context-Dependent Angiogenesis

  2026-09-08

  The 2003 study showed that bestatin, previously associated with anti-angiogenic activity, can instead stimulate microvascular endothelial cell tube formation in a fibrin matrix. Its dose-dependent behavior and weak response to selective CD13 or aminopeptidase inhibitors argue that matrix context and non-CD13 aminopeptidases must be considered when interpreting protease-targeted angiogenesis experiments.

• EZ Cap™ Firefly Luciferase mRNA: QC to Signal

  2026-09-07

  EZ Cap™ Firefly Luciferase mRNA is examined here as a quantitative measurement system, not simply a reporter reagent. Learn how Cap1 architecture, poly(A)-tail capture, transcript quality, and assay controls shape reliable mRNA delivery, translation, and in vivo imaging results.

• BRD4770: G9a Inhibitor Workflow for Cancer

  2026-09-07

  BRD4770 is a practical chemical probe for connecting G9a activity with H3K9 methylation, senescence, and cancer-cell growth. This workflow shows how to handle its solubility limitations, separate enzyme potency from cellular response, and translate findings from PANC-1 into carefully controlled epigenetic assays.

• Hypoxia and Immunometabolism in Tumors

  2026-09-05

  This 2025 review synthesizes how oxygen limitation, nutrient competition, and immune-cell metabolism interact to produce an immunosuppressive tumor microenvironment. Its main practical contribution is a mechanistic framework connecting HIF signaling and metabolic reprogramming with immune dysfunction and the opportunities and limitations of metabolism-directed therapy.

• Brefeldin A: From Trafficking Tool to Translation

  2026-09-04

  Brefeldin A is more than a secretion inhibitor: it is a controllable perturbation of ER–Golgi trafficking, ER stress, cytoskeletal organization, and cancer-cell survival. This thought-leadership perspective connects BFA assay design with biomarker-oriented translational research, while clearly separating established evidence from testable hypotheses in endothelial injury and oncology.

• EZ Cap™ mCherry mRNA as a Delivery Readout

  2026-09-04

  Discover how mCherry mRNA can function as more than a fluorescence reporter: it can reveal delivery, translation, and assay-quality bottlenecks. This evidence-informed guide examines Cap 1 chemistry, modified nucleotides, LNP workflows, and practical controls for reproducible fluorescent protein expression.

• Liraglutide, AVP, and the Brain–Kidney Axis

  2026-09-03

  Greenwood and colleagues integrate a human before-and-after study with rat pituitary proteomics, phosphoproteomics, functional AVP reporter experiments, and renal analysis to examine how liraglutide alters fluid homeostasis. The findings connect reduced circulating vasopressin with sex- and time-dependent synaptic phosphorylation and downstream aquaporin 2 regulation, while also showing why reporter signals require pathway-specific validation.

• CCR5-Positive Extracellular Vesicles in Rheumatoid Arthritis

  2026-09-03

  The reference study identifies CCR5-containing extracellular vesicles released by rheumatoid arthritis synovial fibroblasts as active mediators of cartilage destruction and bone erosion. Using human cell experiments and an adjuvant-induced arthritis rat model, it shows that genetic removal of CCR5 or delivery of Maraviroc within extracellular vesicles reduces inflammatory NF-κB signaling and joint damage, supporting extracellular vesicle-associated CCR5 as a mechanistic and therapeutic target.

• Linoleic Acid: Oxidative Stress Assay Workflows

  2026-09-02

  Linoleic Acid (C18:2(9Z,12Z)) provides a defined lipid input for oxidative stress, membrane, erythrocyte, migration, and essential fatty acid studies. This practical guide connects fresh-stock handling with assay-specific controls and the fasting-linked AMPK–MNK–eIF4E signaling framework.

• Moesin as a Biomarker of Endothelial Injury in Sepsis

  2026-09-02

  The reference study identifies circulating moesin as a candidate indicator of sepsis-associated endothelial injury and links its elevation to disease severity, pulmonary damage, and inflammatory signaling. By combining patient samples, LPS and CLP mouse models, and mechanistic experiments in human microvascular endothelial cells, the work connects biomarker behavior with Rock1/MLC and NF-κB pathway activation.

7788 records 1/520 page Next 12345 下5页 Last page